These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20853184)

  • 1. Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability.
    Santoro L; Breedveld GJ; Manganelli F; Iodice R; Pisciotta C; Nolano M; Punzo F; Quarantelli M; Pappatà S; Di Fonzo A; Oostra BA; Bonifati V
    Neurogenetics; 2011 Feb; 12(1):33-9. PubMed ID: 20853184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome.
    Di Fonzo A; Dekker MC; Montagna P; Baruzzi A; Yonova EH; Correia Guedes L; Szczerbinska A; Zhao T; Dubbel-Hulsman LO; Wouters CH; de Graaff E; Oyen WJ; Simons EJ; Breedveld GJ; Oostra BA; Horstink MW; Bonifati V
    Neurology; 2009 Jan; 72(3):240-5. PubMed ID: 19038853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations.
    Paisán-Ruiz C; Guevara R; Federoff M; Hanagasi H; Sina F; Elahi E; Schneider SA; Schwingenschuh P; Bajaj N; Emre M; Singleton AB; Hardy J; Bhatia KP; Brandner S; Lees AJ; Houlden H
    Mov Disord; 2010 Sep; 25(12):1791-800. PubMed ID: 20669327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.
    Di Fonzo A; Chien HF; Socal M; Giraudo S; Tassorelli C; Iliceto G; Fabbrini G; Marconi R; Fincati E; Abbruzzese G; Marini P; Squitieri F; Horstink MW; Montagna P; Libera AD; Stocchi F; Goldwurm S; Ferreira JJ; Meco G; Martignoni E; Lopiano L; Jardim LB; Oostra BA; Barbosa ER; ; Bonifati V
    Neurology; 2007 May; 68(19):1557-62. PubMed ID: 17485642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism.
    Podhajska A; Musso A; Trancikova A; Stafa K; Moser R; Sonnay S; Glauser L; Moore DJ
    PLoS One; 2012; 7(6):e39942. PubMed ID: 22768177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new Turkish family with homozygous FBXO7 truncating mutation and juvenile atypical parkinsonism.
    Yalcin-Cakmakli G; Olgiati S; Quadri M; Breedveld GJ; Cortelli P; Bonifati V; Elibol B
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1248-52. PubMed ID: 25085748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism.
    Park JS; Mehta P; Cooper AA; Veivers D; Heimbach A; Stiller B; Kubisch C; Fung VS; Krainc D; Mackay-Sim A; Sue CM
    Hum Mutat; 2011 Aug; 32(8):956-64. PubMed ID: 21542062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered apoptosis regulation in Kufor-Rakeb syndrome patients with mutations in the ATP13A2 gene.
    Radi E; Formichi P; Di Maio G; Battisti C; Federico A
    J Cell Mol Med; 2012 Aug; 16(8):1916-23. PubMed ID: 22117566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2.
    Park JS; Sue CM
    Curr Protein Pept Sci; 2017; 18(7):725-732. PubMed ID: 26965689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations.
    Behrens MI; Brüggemann N; Chana P; Venegas P; Kägi M; Parrao T; Orellana P; Garrido C; Rojas CV; Hauke J; Hahnen E; González R; Seleme N; Fernández V; Schmidt A; Binkofski F; Kömpf D; Kubisch C; Hagenah J; Klein C; Ramirez A
    Mov Disord; 2010 Sep; 25(12):1929-37. PubMed ID: 20683840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP13A2 novel mutations causing a rare form of juvenile-onset Parkinson disease.
    Suleiman J; Hamwi N; El-Hattab AW
    Brain Dev; 2018 Oct; 40(9):824-826. PubMed ID: 29903538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and ultrastructural findings in an ataxic variant of Kufor-Rakeb syndrome.
    Pietrzak A; Badura-Stronka M; Kangas-Kontio T; Felczak P; Kozubski W; Latos-Bielenska A; Wierzba-Bobrowicz T; Florczak-Wyspianska J
    Folia Neuropathol; 2019; 57(3):285-294. PubMed ID: 31588715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of nuclear activity of the FBXO7 protein in patients with parkinsonian-pyramidal syndrome (PARK15).
    Zhao T; De Graaff E; Breedveld GJ; Loda A; Severijnen LA; Wouters CH; Verheijen FW; Dekker MC; Montagna P; Willemsen R; Oostra BA; Bonifati V
    PLoS One; 2011 Feb; 6(2):e16983. PubMed ID: 21347293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathologic Findings in a Patient With Juvenile-Onset Levodopa-Responsive Parkinsonism Due to
    Chien HF; Rodriguez RD; Bonifati V; Nitrini R; Pasqualucci CA; Gelpi E; Barbosa ER
    Neurology; 2021 Oct; 97(16):763-766. PubMed ID: 34475127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mutation in ATP13A2 widens the spectrum of Kufor-Rakeb syndrome (PARK9).
    Eiberg H; Hansen L; Korbo L; Nielsen IM; Svenstrup K; Bech S; Pinborg LH; Friberg L; Hjermind LE; Olsen OR; Nielsen JE
    Clin Genet; 2012 Sep; 82(3):256-63. PubMed ID: 21696388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal recessive parkinsonism.
    Bonifati V
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S4-6. PubMed ID: 22166450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis.
    Bras J; Verloes A; Schneider SA; Mole SE; Guerreiro RJ
    Hum Mol Genet; 2012 Jun; 21(12):2646-50. PubMed ID: 22388936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.
    Hansen FH; Skjørringe T; Yasmeen S; Arends NV; Sahai MA; Erreger K; Andreassen TF; Holy M; Hamilton PJ; Neergheen V; Karlsborg M; Newman AH; Pope S; Heales SJ; Friberg L; Law I; Pinborg LH; Sitte HH; Loland C; Shi L; Weinstein H; Galli A; Hjermind LE; Møller LB; Gether U
    J Clin Invest; 2014 Jul; 124(7):3107-20. PubMed ID: 24911152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FBXO7-R498X mutation: phenotypic variability from chorea to early onset parkinsonism within a family.
    Gündüz A; Eken AG; Bilgiç B; Hanagasi HA; Bilgüvar K; Günel M; Başak AN; Ertan S
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1253-6. PubMed ID: 25169713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism.
    Myhre R; Steinkjer S; Stormyr A; Nilsen GL; Abu Zayyad H; Horany K; Nusier MK; Klungland H
    BMC Neurol; 2008 Dec; 8():47. PubMed ID: 19087301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.